[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  M. V. Cunha [@mvcinvesting](/creator/twitter/mvcinvesting) on x 47.9K followers Created: 2025-07-09 13:28:36 UTC JUST IN: $HIMS will enter the Canadian market in 2026. 👀 "Entry to Canada will come as generic semaglutide hits the market for the first time, marking a major step in expanding access to affordable weight loss care." $HIMS plans to offer access to lower-cost treatment options through its digital platform, paired with 24/7 access to licensed providers and personalized, clinically backed care plans. In Canada, branded semaglutide currently costs over C$200/month, often without ongoing clinical support. Generic versions are expected to launch at a meaningful discount — with prices likely to decrease further over time. This move reinforces $HIMS' mission to democratize access to high-quality healthcare across North America. IMO, this is a much smarter move than the acquisition of ZAVA to enter Europe.  XXXXXX engagements  **Related Topics** [hims](/topic/hims) [weight loss](/topic/weight-loss) [affordable](/topic/affordable) [canada](/topic/canada) [$hims](/topic/$hims) [cunha](/topic/cunha) [hims hers](/topic/hims-hers) [stocks consumer defensive](/topic/stocks-consumer-defensive) [Post Link](https://x.com/mvcinvesting/status/1942938943084810325)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
M. V. Cunha @mvcinvesting on x 47.9K followers
Created: 2025-07-09 13:28:36 UTC
JUST IN: $HIMS will enter the Canadian market in 2026. 👀
"Entry to Canada will come as generic semaglutide hits the market for the first time, marking a major step in expanding access to affordable weight loss care."
$HIMS plans to offer access to lower-cost treatment options through its digital platform, paired with 24/7 access to licensed providers and personalized, clinically backed care plans.
In Canada, branded semaglutide currently costs over C$200/month, often without ongoing clinical support.
Generic versions are expected to launch at a meaningful discount — with prices likely to decrease further over time.
This move reinforces $HIMS' mission to democratize access to high-quality healthcare across North America.
IMO, this is a much smarter move than the acquisition of ZAVA to enter Europe.
XXXXXX engagements
Related Topics hims weight loss affordable canada $hims cunha hims hers stocks consumer defensive